Assessment of Concordant Human Papillomavirus Infection With 9-Valent Vaccine Types Across Anogenital Sites in Young Men
Open Access
- 16 December 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (2) , e462-e470
Abstract
Background: The global prevalence of and risk factors associated with same-type HPV infection across multiple anogenital sites among men has not been quantified. Methods: Men aged 16–27 years participating in a multi-country 4-valent HPV vaccine trial (NCT00090285) were assessed at baseline for prevalent HPV infection at penile/scrotal and perineal/perianal sites (heterosexual men [HM] and men who have sex with men [MSM]) and additionally at intra-anal sites (MSM). Concordant infection with 9-valent HPV (9vHPV) vaccine types (6/11/16/18/31/33/45/52/58) was defined as same-type 9vHPV infection at 2 or 3 sites. Results: 3363 HM and 595 MSM were included. Prevalence of concordant 9vHPV infection at 2 anogenital sites was 3.7% among HM and 9.1% among MSM, and 8.2% at 3 sites (including the intra-anal site) among MSM. HPV6 and HPV16 were most likely to occur at multiple anogenital sites in HM and MSM, with strong agreement observed between perineal/perianal and anal sites among MSM for HPV6 (Cohen's kappa, 0.78; 95% CI, .69–.87) and HPV16 (0.61; 95% CI, .50–.73). Conclusions: Concordant anogenital 9vHPV infection was more common among MSM than HM, which is consistent with evidence that MSM are at increased risk of HPV-related cancer across multiple anogenital sites. Clinical Trial Registration: ClinicalTrials.gov, NCT00090285Keywords
Funding Information
- Merck Sharp & Dohme LLC
- Merck
This publication has 27 references indexed in Scilit:
- Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studiesThe Lancet HIV, 2021
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysisThe Lancet Global Health, 2020
- Multisite HPV infections in the United States (NHANES 2003–2014): An overview and synthesisPreventive Medicine, 2019
- Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with menPapillomavirus Research, 2019
- Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2018
- Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenJAMA, 2016
- Seroconversion following anal and genital HPV infection in men: The HIM studyPapillomavirus Research, 2015
- Concurrence of oral and genital human papillomavirus infection in healthy men: a population-based cross-sectional study in rural ChinaScientific Reports, 2015
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign ConditionsVaccine, 2008